Sanjeev Thoran
Sanjeev Thohan, PhD, is a biopharmaceutical executive whose career has consistently centered on translating complex science into executable strategy. His leadership spans large pharmaceutical organizations, public biotech, venture-backed startups, consulting platforms, and advisory roles, giving him a practical understanding of how scientific choices affect clinical timelines, regulatory outcomes, financing needs, and enterprise value.
He has served in senior leadership roles at Exelixis, Novartis NIBR, Xeris Pharmaceuticals, and Kinnate Biopharma, and currently serves as Chief Scientific Officer, Fractional CSO, consultant, founder, president, and Scientific Advisory Board member across multiple organizations. This trajectory reflects a progressive expansion from technical expertise in metabolism and toxicology to full-spectrum development leadership and board-facing strategic influence.